"ScreenPoint Medical is a fast growing company that develops and markets AI products and services to improve early detection of breast cancer. The company was founded in 2014 in the Netherlands by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection.
We are focused on helping to improve breast cancer survival rates by detecting cancers earlier so that treatment can be more effective and less invasive. We are working with breast clinicians to continually improve the clinically proven deep learning algorithms in Transpara™. We are committed to further improve accuracy, consistency and reduce unnecessary recalls, a common cause of anxiety for women undergoing mammography.
ScreenPoint Inc. can be reached on 1-833-MammoAI (626-6624) for more information."